Phylogica Limited  

(Public, ASX:PYC)   Watch this stock  
Find more results for PYC
May 29 - Close
ASX data delayed by 20 mins - Disclaimer
Currency in AUD
Range     -
52 week 0.01 - 0.05
Open     -
Vol / Avg. 0.00/1.49M
Mkt cap 30.06M
P/E     -
Div/yield     -
EPS 0.00
Shares 1.00B
Beta     -
Inst. own     -

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin -17.67% -466.29%
Operating margin -282.78% -740.98%
EBITD margin - -710.32%
Return on average assets -5.94% -96.00%
Return on average equity -7.30% -132.60%
Employees 20 -
CDP Score - -


100 Roberts Rd
+61-8-94897777 (Phone)
+61-8-94897700 (Fax)

Website links


Phylogica Limited is an Australia-based company, engaged in provision of drug discovery services to the pharmaceutical industry utilizing the Company’s Phylomer peptide libraries and screening capabilities. The Company operates in a single geographical location being Australia.

Officers and directors

Richard Miles Miles Hopkins Chief Executive Officer, Executive Director
Graeme Raymond Boden CPA Chief Financial Officer, Joint Company Secretary
Age: 65
Paul Michael Watt Chief Scientific Officer
Age: 48
Natasha Forde Joint Company Secretary
Douglas John Wilson Non-Executive Chairman
Bernard Edward Frederick Hockings Director
Jeremy Laurence Curnock-Cook Non-Executive Director
Age: 63
Bruce Fielding McHarrie Non-Executive Director
Age: 55